Codon 54 polymorphism of the human intestinal fatty acid binding protein 2 gene is associated with dyslipidemias but not with insulin resistance in patients with familial combined hyperlipidemia

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 6, 1997, Pages 1039-1044

  Pihlajamäki, Jussi ^a   Rissanen, Johanna ^a   Heikkinen, Sami ^a   Karjalainen, Leena ^a   Laakso, Markku ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Familial combined hyperlipidemia; Fatty acid binding protein 2; Insulin resistance

Indexed keywords

APOLIPOPROTEIN B; FATTY ACID BINDING PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NEUTRAL INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CODON; FAMILIAL HYPERLIPEMIA; FEMALE; GENETIC POLYMORPHISM; GENETIC SCREENING; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; LIPID METABOLISM; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0030926540     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.6.1039     Document Type: Article

References (38)

1. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG. Hyperlipidemia in coronary heart disease, II: genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest. 1973;52:1544-1568.
2. Nikkilä EA, Aro A. A family study of lipids and lipoproteins in coronary heart disease. Lancet. 1973;l:954-958.
3. Chait A, Albers JJ, Brunzell JD. Very low density lipoprotein overproduction in genetic forms of hypertriglyceridemia. Eur J Clin Invest. 1980;10:17-22.
4. Janus ED, Nicoll AM, Turner PR, Magill P, Lewis B. Kinetic bases of the primary hyperlipidaemias: studies of apolipoprotein turnover in genetically defined subjects. Eur J Clin Invest. 1980;10:161-172.
5. Conner JA, Coates PM, Bennett MJ, Cryer DR, Le NA. Familial combined hyperlipidaemia: use of stable isotopes to demonstrate overproduction of very-low-density lipoprotein apolipoprotein B by the liver. J Inherit Me tab Dis. 1991;14:915-922.
6. Venkatesan S, Cullen P, Pacy P, Halliday D, Scott J. Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglycéride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia. Arterioscler Thromb. 1993;13:1110-1118.
7. Krauss RM, Albers JJ, Brunzell JD. An apolipoprotein B-enriched low density lipoprotein subspecies in familial combined hyperlipidemia. Clin Res. 1983;31:503a.
8. Laakso M, Sarlund H, Mykkänen L. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis. 1990;10:223-231.
9. Karhapää P, Voutilainen E, Malkki M, Laakso M. Obese men with type IIB hyperlipidemia are insulin resistant. Arterioscler Tliromb. 1993:13:1469-1475.
10. Hunt SC, Wu LL, Hopkins PN, Stults BM, Kuida H, Ramirez ME, Lalouel JM, Williams RR. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia: study of Utah patients with familial dyslipidemic hypertension. Arteriosclerosis. 1989;9:335-344.
11. Reaven GM. The role of insulin resistance and hyperinsulinemia in coronary heart disease. Melab Clin Exp. 1992;41(suppl1):16-19.
12. Lowe JB, Sacchettini JC, Laposata M, McQuillan JJ, Gordon JI. Expression of rat intestinal fatty acid-binding protein in Escherichia coli: purification and comparison of ligand binding characteristics with that of Escherichia coli-derived rat liver fatty acid-binding protein. J Biol Chem. 1987;262:5931-5937.
13. Baier LJ, Sacchettini JC, Knowler WC, Eads J, Paolisso G, Tataranni PA, Mochizuki H, Bennett PH, Bogardus C, Prochazka M. An amino acid substitution in the human intestinal fatly acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest. 1995;95:1281-1287.
14. De la Chapelle A. Disease gene mapping in isolated human populations: the example of Finland. J Med Genet. 1993;30:857-865.
15. Haffner SM, Karhapää P, Mykkänen L, Laakso M. Insulin resistance, body fat distribution, and sex hormones in men. Diabetes. 1994;43: 212-219.
16. World Health Organization. Diabetes Mellitus: Report of a WHO Study Group. Geneva, Switzerland: World Health Organization; 1985. Technical Report Series, No. 727.
17. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and insulin resistance. Am J Physiol. 1979;237:E214-E223.
18. Karhapää P, Uusitupa M, Voutilainen E, Laakso M. Effects of bezafibrate on insulin sensitivity and glucose tolerance in subjects with familial combined hyperlipidemia. Clin Pharmacol Ther. 1992;52:620-626.
19. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocrinol Rev. 1985;5:45-86.
20. Takala J, Keinänen O, Väisänen P, Kari A. Measurement of gas exchange in intensive care: laboratory and clinical validation of a new device. Crit Care Med. 1989;17:1041-1047.
21. Laakso M, Uusitupa M, Takala J, Majander H, Reijonen T, Penttilä I. Effects of hypocaloric diet and insulin therapy on metabolic control and mechanisms of hyperglycemia in obese non-insulin-dependent diabetic subjects. Metabolism. 1988:37:1092-1100.
22. Ferrannini E. The theoretical bases of indirect calorimetry. Metabolism. 1988:37:287-301.
23. Penttilä IM, Voutilainen E, Laitinen P, Juutilainen P. Comparison of different analytical and precipitation methods for the direct estimation of serum high density lipoprotein cholesterol. Scand J Clin Lab Invest. 1984:41:353-360.
24. Hawk PB, Oser BL, Summerson WH. Practical Physiological Chemistry. 12th ed. Toronto, Canada: Blakiston; 1947:814-822.
25. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as singlestrand conformation polymorphisms. Proc Natl Acad Sci USA. 1989;86:2766-2770.
26. Nevin DN, Brunzell JD, Deeb SS. The LPL gene in individuals with familial combined hyperlipidemia and decreased LPL activity. Arterioscler Thromb. 1994;14:869-873.
27. Kretz KA, Carson GS, O'Brien JS. Direct sequencing from low-melt agarose with Sequenase. Nucleic Acids Res. 1989:17:5864.
28. Jarvik GP, Brunzell JD, Austin MA, Krauss RM, Motulsky AG, Wijsman E. Genetic predictors of FCHL in four large pedigrees: influence of apoB level major locus predicted genotype and LDL subclass phenotype. Arterioscler Thromb. 1994;14:1687-1694.
29. Cullen P, Farren B, Scott J, Farrall M. Complex segregation analysis provides evidence for a major gene acting on serum triglyceride levels in 55 British families with familial combined hyperlipidemia. Arterioscler Thromb. 1994;14:1233-1249.
30. Castro-Cabezas M, de-Bruin TW, de-Valk HW, Shoulders CC, Jansen H, Erkelens DW. Impaired fatty acid metabolism in familial combined hyperlipidemia: a mechanism associating hepatic apolipoprotein B overproduction and insulin resistance. J Clin Invest. 1993:92:160-168.
31. Cabezas Mc, de Bruin TW, Kock LA, Kortlandt W, van LindeSibenius-Trip M, Jansen H, Erkelens DW. Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion. Metabolism. 1993:42:497-503.
32. Cianflone KM, Yasruel Z, Rodriguez MA, Vas D, Sniderman AD. Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge. J Lipid Res. 1990;31:2045-2055.
33. Randle PJ, Hales CN, Garland PB, Newsholme EA. The glucose fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963;l:785-789.
34. McNamara JR, Jenner JL, Li Z, Wilson PWF, Schaefer EJ. Change in LDL particle size associated with change in plasma triglyceride concentration. Arterioscler Thromb. 1992;12: 1284-1290.
35. Lagrost L, Gambert P, Lallemant C. Combined effects of lipid transfers and lipolysis on gradient gel patterns of human plasma LDL. Arterioscler Thromb. 1994;14:1327-1336.
36. Austin MA, Brunzell JD, Fitch WL, Krauss RM. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Arteriosclerosis. 1990;10:520-530.
37. Hokanson JE, Austin MA, Zambon A, Brunzell JD. Plasma triglyceride and LDL heterogeneity in familial combined hyperlipidemia. Arterioscler Thromb. 1993;13:427-434.
38. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988;13:1917-1921.